Literature DB >> 23886826

Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration.

Silvia Rossi1, Caterina Motta, Valeria Studer, Francesca Barbieri, Fabio Buttari, Alessandra Bergami, Giulia Sancesario, Sergio Bernardini, Gottardo De Angelis, Gianvito Martino, Roberto Furlan, Diego Centonze.   

Abstract

BACKGROUND: Chronic inflammation leads to gray matter damage in progressive multiple sclerosis (MS), but the mechanism linking inflammation and neurodegeneration is unclear.
OBJECTIVE: The objective of this paper is to investigate the synaptic mechanism of inflammatory neurodegeneration in progressive forms of MS.
METHODS: Cytokine and neurofilament-light were determined in cerebrospinal fluid (CSF) of MS patients. In vitro electrophysiology and cell swelling experiments were performed to measure the effects of inflammatory cytokines in the CSF of MS patients on synaptic transmission and neuronal integrity.
RESULTS: Tumor necrosis factor-α (TNF) was higher in CSF of progressive MS subjects, and caused excitotoxic neuronal death in vitro. In murine brain slices incubated in the presence of CSF from progressive MS, in fact, we observed increased spontaneous excitatory postsynaptic currents (sEPSCs) and glutamate-mediated neuronal swelling through a mechanism dependent on enhanced TNF signaling. We also suggested a pathogenic role of B cells in TNF CSF increase, exacerbation of glutamatergic transmission and neuronal damage, since CNS depletion of B cells with intrathecal rituximab caused a dramatic reduction of TNF levels, of TNF-induced sEPSC alterations, and of neurofilament CSF concentrations in a patient with progressive MS.
CONCLUSION: Our results point to TNF as a primary neurotoxic molecule in progressive forms of MS.

Entities:  

Keywords:  B cells; TNF-α; cerebrospinal fluid; glutamate; inflammation; synaptic transmission

Mesh:

Substances:

Year:  2013        PMID: 23886826     DOI: 10.1177/1352458513498128

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  52 in total

1.  Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.

Authors:  Jeffery D Haines; Oscar G Vidaurre; Fan Zhang; Ángela L Riffo-Campos; Josefa Castillo; Bonaventura Casanova; Patrizia Casaccia; Gerardo Lopez-Rodas
Journal:  Mult Scler       Date:  2015-05-06       Impact factor: 6.312

2.  Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course.

Authors:  Mario Stampanoni Bassi; Ennio Iezzi; Doriana Landi; Fabrizia Monteleone; Luana Gilio; Ilaria Simonelli; Alessandra Musella; Georgia Mandolesi; Francesca De Vito; Roberto Furlan; Annamaria Finardi; Girolama A Marfia; Diego Centonze; Fabio Buttari
Journal:  J Neurol       Date:  2018-08-28       Impact factor: 4.849

Review 3.  The role of glutamate and its receptors in multiple sclerosis.

Authors:  Ivana R Stojanovic; Milos Kostic; Srdjan Ljubisavljevic
Journal:  J Neural Transm (Vienna)       Date:  2014-03-15       Impact factor: 3.575

Review 4.  Deep brain stimulation: are astrocytes a key driver behind the scene?

Authors:  Albert J Fenoy; Laurent Goetz; Stéphan Chabardès; Ying Xia
Journal:  CNS Neurosci Ther       Date:  2014-01-24       Impact factor: 5.243

5.  Comparison of bead array and glass nanoreactor multi-analyte platforms for the evaluation of CNS and peripheral inflammatory markers during HIV infection.

Authors:  Albert M Anderson; Minh Ly Nguyen; Michael Potter; Debra Rosario; Katarzyna Kempinska; Ronald J Ellis; Mitchell Diccianni; Scott L Letendre
Journal:  J Immunol Methods       Date:  2018-11-20       Impact factor: 2.303

6.  Chronic TNFα Exposure Induces Robust Proliferation of Olfactory Ensheathing Cells, but not Schwann Cells.

Authors:  Karen L Lankford; Edgardo J Arroyo; Jeffery D Kocsis
Journal:  Neurochem Res       Date:  2017-05-11       Impact factor: 3.996

Review 7.  Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus.

Authors:  Tommaso Schirinzi; Giulia Maria Sancesario; Giulia Di Lazzaro; Alessio D'Elia; Paola Imbriani; Simona Scalise; Antonio Pisani
Journal:  J Neural Transm (Vienna)       Date:  2018-01-20       Impact factor: 3.575

8.  Role of tumor necrosis factor-alpha in zebrafish retinal neurogenesis and myelination.

Authors:  Xu-Dan Lei; Yan Sun; Shi-Jiao Cai; Yang-Wu Fang; Jian-Lin Cui; Yu-Hao Li
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

9.  Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.

Authors:  Sayonara R Oliveira; Ana Paula Kallaur; Edna M V Reiche; Damacio R Kaimen-Maciel; Carolina Panis; Marcell Alysson B Lozovoy; Helena K Morimoto; Michael Maes; Isaias Dichi; Andrea Name Colado Simão
Journal:  Mol Neurobiol       Date:  2016-03-30       Impact factor: 5.590

10.  Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.

Authors:  Oscar G Vidaurre; Jeffery D Haines; Ilana Katz Sand; Kadidia P Adula; Jimmy L Huynh; Corey A McGraw; Fan Zhang; Merina Varghese; Elias Sotirchos; Pavan Bhargava; Veera Venkata Ratnam Bandaru; Giulio Pasinetti; Weijia Zhang; Matilde Inglese; Peter A Calabresi; Gang Wu; Aaron E Miller; Norman J Haughey; Fred D Lublin; Patrizia Casaccia
Journal:  Brain       Date:  2014-06-03       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.